SC Filed 2021-05-03 Event — SEC 0001193125-21-148141 →

Versant Venture Capital VI, L.P. → Aligos Therapeutics, Inc. ALGS

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 12/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Filer track record (4 filings): 0% 90d win rate, +0.0% 90d edge
Elevated short days-to-cover (21.7 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

15 filings by this filer

14 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 21.74

707,471 shares short · -0.2% vs prior

Other 13D/G Filings on Aligos Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-24	SCHEDULE 13D	BLATT LAWRENCE	5.60%	316,228	view →
2021-06-21	SC	Novo Holdings A/S	—	—	view →
2021-06-21	SC	Versant Venture Capital VI, L.P.	—	—	view →

Other Filings by Versant Venture Capital VI, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-09	SCHEDULE	Monte Rosa Therapeutics, Inc. GLUE	3.40%	2,236,708	view →
2025-11-12	SCHEDULE	Monte Rosa Therapeutics, Inc. GLUE	5.10%	3,334,669	view →
2025-09-23	SCHEDULE	LAVA Therapeutics NV	—	—	view →
2025-08-13	SCHEDULE	Tempest Therapeutics, Inc. TPST	3.70%	162,972	view →
2025-02-11	SCHEDULE	Tempest Therapeutics, Inc. TPST	4.80%	2,118,644	view →
2022-01-13	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-10-27	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-06-21	SC	Aligos Therapeutics, Inc. ALGS	—	—	view →
2021-05-24	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-04-05	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-03-01	SC	Oyster Point Pharma, Inc.	—	—	view →
2020-12-03	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →
2020-11-23	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →
2020-09-25	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →